Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Otolaryngol ; 44(4): 103890, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37058911

RESUMO

OBJECTIVE: When inhaled, cannabis smoke interacts with airway tissues, including the nasal mucosa, which may lead to nasal pathologies. We examined the effect of cannabis smoke condensate (CSC) on nasal epithelial cell and tissue behaviors. METHODS: Human nasal epithelial cells were exposed or not to CSC at different concentrations (1, 5, 10, and 20 %) and for different durations. Cell adhesion and viability were assessed, as well as post-wound cell migration and lactate dehydrogenase (LDH) release. RESULTS: The nasal epithelial cells showed a larger cell size and a faint nucleus following exposure to CSC, compared to that observed in that control. This was supported by fewer adherent cells present after exposure for either 1 or 24 h to 5, 15, and 20 % CSC. CSC also had a significant toxic effect by reducing cell viability after both 1 and 24 h of exposure. This toxic effect was significant even at a low concentration (1 %) of CSC. The effects on nasal epithelial cell viability were confirmed by the decrease in cell migration. After the scratch and subsequent exposure to CSC for either 6 or 24 h, a complete inhibition of nasal epithelial cell migration was observed, compared to that found in the controls. CSC was toxic to the nasal epithelial cells, as the level of LDH significantly increased following cell exposure all CSC concentrations. CONCLUSION: Cannabis smoke condensate had a negative effect on several nasal epithelial cell behaviors. These findings indicate that cannabis smoke could be a threat to nasal tissues and ultimately lead to nasal and sinus disorders.


Assuntos
Cannabis , Fumaça , Humanos , Fumaça/efeitos adversos , Células Cultivadas , Adesão Celular , Nicotiana , Células Epiteliais
2.
J Otolaryngol Head Neck Surg ; 50(1): 36, 2021 Jun 16.
Artigo em Inglês | MEDLINE | ID: mdl-34134762

RESUMO

OBJECTIVES: Many experts feel that in the absence of well-defined goals for success, they have an easier time identifying failure. As success ought to not be defined only by absence of failure, we aimed to define optimal outcomes for endoscopic sinus surgery (ESS) in chronic rhinosinusitis (CRS) by obtaining expert surgeon perspectives. METHODS: A total of 12 surgeons participated in this targeted consultation. Face to face semi-structured interviews were performed with expert surgeons in the field of CRS and ESS. General impressions and personal definitions of acceptable operative success and optimal operative outcomes were compiled and summarized. RESULTS: According to an expert survey, patients' main objectives are an improvement in their chief complain, a general improvement in quality of life (QoL), and a better overall symptomatic control. The most important aspects of endoscopy for defining a successful intervention were an adequate mucus circulation, a healthy mucosa, minimal edema, and patency of all explored cavities or ostia. In the assessment of surgical outcomes, it was determined that both objective and patient reported data must be carefully examined, with more attention given to subjective outcomes. CONCLUSIONS: According to data gathered from a Canadian expert consultation, a definition of success must be based on both subjective data and nasal endoscopy. We propose to define an acceptable outcome as either a subjective improvement of at least the minimal clinically improvement difference of a validated patient reported outcome questionnaire, along with a satisfactory endoscopic result (1) or a complete subjective resolution with a sub-optimal endoscopy (2).


Assuntos
Endoscopia/métodos , Prova Pericial/métodos , Procedimentos Cirúrgicos Otorrinolaringológicos/métodos , Seios Paranasais/cirurgia , Encaminhamento e Consulta , Rinite/cirurgia , Sinusite/cirurgia , Adulto , Canadá , Doença Crônica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
3.
Am J Otolaryngol ; 41(6): 102686, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32866847

RESUMO

OBJECTIVE: Upon use, e-cigarette aerosol comes in contact with various mucosal tissues, including the nasal epithelium, which may lead to nasal pathologies. We therefore assessed the effect of e-cigarettes on nasal epithelial cell and tissue behaviours. METHODS: Human primary nasal epithelial cells and engineered 3D nasal mucosa tissues were exposed or not to either e-cigarette aerosol or standard cigarette smoke. We then evaluated cell viability and lactate dehydrogenase (LDH) activity. With the tissues analysed tissue structure, the expression of Ki67 proliferating marker, and the secretion of pro-inflammatory cytokines by the engineered nasal mucosa. RESULTS: The nasal epithelial cells exposed to e-cigarettes displayed a larger cell size and a faint nucleus following exposure to e-cigarettes. This is supported by the increased levels of LDH activity following exposure to e-cigarettes, compared to that observed in the control. Tissues exposed to e-cigarette aerosol displayed a structural deregulation, with more large-sized cells, fewer Ki67-positive cells, and a reduced proliferation rate, compared to that observed in the non-exposed tissues. Cytokine measurements showed high levels of IL-6, IL-8, TNFα, and MCP-1, demonstrating that e-cigarettes activated pro-inflammatory cytokine responses. CONCLUSION: E-cigarette aerosol showed adverse effects on nasal epithelial cells and nasal engineered mucosa tissue. These findings indicate that e-cigarettes could be a threat to nasal tissues and may impair the innate immune function of nasal epithelial cells.


Assuntos
Crescimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Citocinas/metabolismo , Vapor do Cigarro Eletrônico/efeitos adversos , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Expressão Gênica/efeitos dos fármacos , Imunidade Inata/efeitos dos fármacos , Mediadores da Inflamação/metabolismo , Antígeno Ki-67/genética , Antígeno Ki-67/metabolismo , Mucosa Nasal/citologia , Fumaça/efeitos adversos , Aerossóis , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Células Epiteliais/imunologia , Humanos , L-Lactato Desidrogenase/metabolismo , Engenharia Tecidual
4.
Cleft Palate Craniofac J ; 53(3): 309-16, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-25898150

RESUMO

OBJECTIVE: To determine whether there are differences in the anatomical cleft measurements between patients with isolated cleft palate (CP) with or without Pierre Robin sequence (PR) and those with cleft lip and palate (CLP). DESIGN: Prospective case series. SETTING: Tertiary care university-based medical center. PATIENTS: From 1993 to 2012, CP and CLP patients were prospectively enrolled in a database. MAIN OUTCOME MEASURES: Several anatomical cleft parameters were recorded with precise measurements at the time of palatoplasty under general anesthesia. RESULTS: One hundred twenty-five patients were included in our study: 50 patients in the CP without PR group, 87 patients in the CP with or without PR (CPPR) group, and 38 patients in the CLP group. Patients in the CLP group had increased values for the following parameters compared to patients with CP and patients with CPPR: nasopharyngeal depth (P = .02 and P = .01, respectively); cleft width at posterior hard palate border (P < .001 and P < .001); width of the dental arch (P < .001 and P < .001); and total cleft length (P < 01 and P < .001). For cleft width at the soft palate level, there was a significant difference between the CP and CLP groups (P = .005). We found no statistically significant differences between the groups (CLP versus CP and CPPR, respectively) for the length of the soft palate (P = .74, P = .21) or for the length of the hard palate (P = .19, P = .08). CONCLUSION: There are significant differences in cleft and palate measurements between CLP and CP patients that may be useful to predict the occurrence of velopharyngeal insufficiency or other complications.


Assuntos
Fenda Labial/patologia , Fissura Palatina/patologia , Síndrome de Pierre Robin/patologia , Fenda Labial/cirurgia , Fissura Palatina/cirurgia , Feminino , Humanos , Lactente , Masculino , Síndrome de Pierre Robin/cirurgia , Estudos Prospectivos , Resultado do Tratamento , Insuficiência Velofaríngea
5.
J Antimicrob Chemother ; 57(4): 685-90, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16473919

RESUMO

BACKGROUND: Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola are three major aetiological agents of chronic periodontitis. The strong proteolytic activities of these bacteria are critical to their survival since their energy source is obtained from peptides and amino acids derived from proteins. In addition, proteases are important factors contributing to periodontal tissue destruction by a variety of mechanisms, including direct tissue degradation and modulation of host inflammatory responses. OBJECTIVES: The aim of this study was to investigate the effect of non-dialysable material (NDM) prepared from cranberry juice concentrate on the proteolytic activities of P. gingivalis, T. forsythia and T. denticola. METHODS: The effect of NDM on gingipain and dipeptidyl peptidase IV (DPP IV) activities of P. gingivalis, trypsin-like activity of T. forsythia and chymotrypsin-like activity of T. denticola was evaluated using synthetic chromogenic peptides. In addition, the capacity of P. gingivalis to degrade fluorescein-labelled type I collagen and fluorescein-labelled transferrin in the presence of NDM was evaluated by fluorometry. RESULTS: NDM dose-dependently inhibited the proteinases of P. gingivalis, T. forsythia and T. denticola as well as type I collagen and transferrin degradation by P. gingivalis. CONCLUSIONS: These results suggest that NDM has the potential to reduce either the proliferation of P. gingivalis, T. forsythia and T. denticola in periodontal pockets or their proteinase-mediated destructive process occurring in periodontitis.


Assuntos
Bacteroidetes/efeitos dos fármacos , Periodontite/microbiologia , Porphyromonas gingivalis/efeitos dos fármacos , Inibidores de Proteases/farmacologia , Treponema denticola/efeitos dos fármacos , Vaccinium macrocarpon/química , Bacteroidetes/enzimologia , Endopeptidases/metabolismo , Infecções por Bactérias Gram-Negativas/microbiologia , Peso Molecular , Porphyromonas gingivalis/enzimologia , Inibidores de Proteases/química , Treponema denticola/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...